Jason Kolbert's Stock Ratings

EF Hutton Analyst

Jason Kolbert is an analyst at EF Hutton. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 07/12/2024

Overall Average Return

-19.1%

Smart Score

41.3%

Overall Average Return Percentile

12th

Number of Ratings

18
Buy NowGet Alert
07/15/2024CTXRBuy Now
Citius Pharma
$0.77684.01% → $6Initiates → BuyGet Alert
02/28/2024TNXPBuy Now
Tonix Pharmaceuticals
$0.60400% → $96Initiates → BuyGet Alert
08/03/2023BJDXBuy Now
Bluejay Diagnostics
$0.58DowngradeBuy → NeutralGet Alert
07/17/2023HILSBuy Now
Hillstream BioPharma
DowngradeBuy → NeutralGet Alert
03/03/2023GOVXBuy Now
Geovax Labs
$3.0232.45% → $60Initiates → BuyGet Alert
02/06/2023CETXBuy Now
Cemtrex
$0.259100%$7.62 → $21.9MaintainsBuyGet Alert
01/30/2023GNPXBuy Now
Genprex
$2.0050% → $120Initiates → BuyGet Alert
01/06/2023ZOMBuy Now
Zomedica
→ $6Initiates → BuyGet Alert
11/11/2022BCDABuy Now
BioCardia
$3.11DowngradeBuy → NeutralGet Alert
09/16/2022ADTXBuy Now
Aditxt
$1.54DowngradeBuy → NeutralGet Alert
08/29/2022SMFLBuy Now
Smart for Life
$2.55213.73% → $25200Initiates → BuyGet Alert
07/18/2022DYAIBuy Now
Dyadic International
$1.46DowngradeBuy → NeutralGet Alert
05/16/2022KTRABuy Now
Kintara Therapeutics
$0.28DowngradeBuy → NeutralGet Alert
02/08/2022KNWNBuy Now
Know Labs
→ $7Initiates → BuyGet Alert
01/31/2022SFETBuy Now
Safe-T Gr
→ $60Initiates → BuyGet Alert
01/12/2022BJDXBuy Now
Bluejay Diagnostics
$0.581635.81% → $1600Initiates → BuyGet Alert
07/28/2020SNGXBuy Now
Soligenix
$6.71-70.19%$720 → $480DowngradeBuy → NeutralGet Alert
08/14/2017SNGXBuy Now
Soligenix
$6.71-25.48%$960 → $1200MaintainsBuyGet Alert